Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

AKT activation directs LPA-induced invasion of ovarian cancer cells through HIF1α-ETS-1 axis

ABSTRACT: We sequenced the global transcriptome of human ovarian cancer cell line treated Vs untreated to identify the pathways and genes that are regulating the metabolite-induced invasion in ovarian cancer cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE87087 | GEO | 2017/08/15

SECONDARY ACCESSION(S): PRJNA343474

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.

Project description: Not available

| S-EPMC5984708 | biostudies-literature

Ets-1 over-expression in ovarian cancer cells

Project description:The transcription factor Ets-1 is over-expressed in a wide variety of cancers, and has been strongly associated with the upregulation of factors involved in metastasis and angiogenesis. In this study, we created an inducible Ets-1 over-expressing ovarian cancer cell line from parental 2008 ovarian cancer cells that do not express detectable levels of Ets-1 protein. This microarray compares the stable over-expressing Ets-1 ovarian cancer cell line (2008-Ets1) to their parental 2008 cells to examine differences in gene expression beyond metastasis and angiogenesis. Two samples were used: 2008 ovarian cancer cells, and 2008-Ets1 ovarian cancer cells which over-express Ets-1. Included in this analysis are three independent replicates for each sample.

2010-06-08 | E-GEOD-21129 | biostudies-arrayexpress

Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.

Project description: Not available

| S-EPMC8437293 | biostudies-literature

Ets-1 over-expression in ovarian cancer cells

2010-05-31 | GSE21129 | GEO

Identification of LPA-LPAR-GNA12 driven Gene signatures and Key Pathways in Ovarian Cancer

Project description:Lysophosphatidic acid (LPA) and LPA-receptor (LPAR)-activated G-protein alpha subunits encoded by GNAi2, GNA12, and GNA13 play a crucial role in ovarian cancer progression. While the general signaling mechanism regulated by LPA-LPAR-signaling had previously been characterized, the global transcriptomic network regulated by individual G protein alpha-subunits in ovarian cancer pathophysiology remains largely unknown. To define the specific oncogenic networks regulated by LPA-stimulated GNAi2, GNA12, and GNA13 in ovarian cancer, transcriptomic analyses were carried out using SKOV3 cells in which the expression of GNAi2, GNA12, or GNA134 was silenced in an Agilent SurePrint G3 Human Comparative Genomic Hybridization 8x60 microarray platform.

2021-08-25 | GSE173214 | GEO

Project description: Not available

| S-EPMC2077898 | biostudies-literature

IKKe coordinates invasion and metastasis

Project description:IKKe was identified previously as a breast cancer oncogene and was associated with poor clinical outcome in ovarian cancer. In order to elucidate functional roles of IKKe, we used microarray analysis to identify genes changed upon IKKe shRNA knockdown and compared with genes affected in ovarian cancers IKKe was knockdowned by 2 different IKKe shRNAs in Ovcar5 in 6 replicates and candidate downstream targets were selected if changed by both shRNAs

2012-11-16 | E-GEOD-42320 | biostudies-arrayexpress

IKKe coordinates invasion and metastasis

2012-11-16 | GSE42320 | GEO

CSGALNACT2 Restricts Ovarian Cancer Migration and Invasion by Modulating MAPK/ERK Pathway through DUSP1

Project description:Abstract Purpose Ovarian cancer is one of the leading causes of cancer-related death among women. CSGALNACT2 is a vital Golgi transferase and is related to a variety of human diseases. However, its expression pattern and function in ovarian cancer remain uncertain. Methods The Cancer Genome Atlas and GEPIA databases were used to assess the expression of CSGALNACT2 in ovarian cancer patients. RNA-seq, qRT-PCR, and IHC were used to verify the expression of CSGALNACT2 in ovarian cancer tissues. Then, in vivo and in vitro experiments were conducted to evaluate the role of CSGALNACT2 in the progression of ovarian cancer. RNA-seq and GSEA were used to reveal the potential biological function and oncogenic pathways of CSGALNACT2. Results We demonstrated that the mRNA expression and protein level of CSGALNACT2 were significantly downregulated in ovarian cancer and ovarian cancer metastatic tissues. CSGALNACT2 can significantly inhibit the migration, invasion, and clonogenic growth of ovarian cancer in vitro and is progressively lost during ovarian cancer progression in vivo. CSGALNACT2 suppresses ovarian cancer migration and invasion via DUSP1 modulation of the MAPK/ERK pathway through RNA-seq, KEGG analysis, and Western blotting. Moreover, CSGALNACT2 expression was correlated with immune cell infiltration and had prognostic value in different immune cell-enriched or decreased ovarian cancer. In addition, patients with CSGALNACT2 downregulation are less likely to benefit from immunotherapy. Conclusion As an ovarian cancer suppressor gene, CSGALNACT2 inhibits the development of ovarian cancer, and it might be used as a prognostic biomarker in patients with ovarian cancer.

2023-12-28 | GSE246892 | GEO

The miR-193a-5p/NCX2/AKT axis promotes invasion and metastasis of osteosarcoma.

Project description: Not available

| S-EPMC8408106 | biostudies-literature